DigestRedComo funciona
Red
/
Empresas
Ne
No verificado

Newleos Therapeutics, Inc.

Sobre qué escribimos

BiotecnologíaFarmacéuticaMedicina - VariosPsiquiatríaSalud

8 Comunicados de prensa

Ver todos los comunicados de prensa
21/10/2025
Newleos Therapeutics Appoints Timothy Noyes as President and Chief Executive Officer
Fuente
Newleos Therapeutics, Inc.
Editor
Business Wire
1.00
0
15/10/2025
Psiquiatría
Salud
Medicina - Varios
Farmacéutica
Biotecnología
Eventos
Newleos Therapeutics CEO David Donabedian Recognized by Goldman Sachs as One of the Most Exceptional Entrepreneurs at the 2025 Builders and Innovators Summit
Fuente
Newleos Therapeutics, Inc.
Editor
Business Wire
1.00
0
30/09/2025
Psiquiatría
Higiene alimentaria
Salud
Medicina - Varios
Farmacéutica
Biotecnología
Industria
Newleos Therapeutics Announces Clinical Progress Across Neuropsychiatric Pipeline
Fuente
Newleos Therapeutics, Inc.
Editor
Business Wire
1.00
0
09/09/2025
Psiquiatría
Ciencia
Medicina - Varios
Biotecnología
Salud
Farmacéutica
Eventos
Industria
Newleos Therapeutics Announces Poster Presentation to be Featured at the 2025 World Congress of Biological Psychiatry
Fuente
Newleos Therapeutics, Inc.
Editor
Business Wire
1.00
0
23/07/2025
Psiquiatría
Salud
Medicina - Varios
Farmacéutica
Biotecnología
Mercado laboral
Industria
Newleos Therapeutics Appoints Stephen Brannan to Board of Directors and Announces NTX-1955 Clinical Progress in Generalized Anxiety Disorder
Fuente
Newleos Therapeutics, Inc.
Editor
Business Wire
1.00
0
29/04/2025
Mercado laboral
Industria
Psiquiatría
Ciencia
Medicina - Varios
Biotecnología
Salud
Farmacéutica
Sanidad
Newleos Therapeutics Announces Clinical Advisory Board to Support Key Neuropsychiatry Programs
Fuente
Newleos Therapeutics, Inc.
Editor
Business Wire
1.00
0
08/04/2025
Mercado laboral
Biotecnología
Psiquiatría
Salud
Farmacéutica
Medicina - Varios
Newleos Therapeutics Expands Leadership Team to Advance its Clinical-Stage Neuropsychiatric Programs and Drive Corporate Growth
Fuente
Newleos Therapeutics, Inc.
Editor
Business Wire
1.00
0
13/02/2025
Finanzas
Biotecnología
Farmacéutica
Salud
Psiquiatría
Asociaciones/Profesionales
Medicina - Varios
Newleos Therapeutics Debuts with $93.5 Million Oversubscribed Series A Financing to Transform the Treatment of Neuropsychiatric Disorders through the Advancement of Novel Medicines
Fuente
Newleos Therapeutics, Inc.
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0